Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Olmesartan 40 mg + hydrochlorothiazide 12.50 mg tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹99/-
Ramipril 5 mg Tablet is a long-acting angiotensin-converting enzyme (ACE) inhibitor used primarily to treat high blood pressure and heart failure. It works by inhibiting the enzyme responsible for converting angiotensin I into angiotensin II, a potent vasoconstrictor. This action relaxes blood vessels, lowers vascular resistance, and reduces blood pressure while decreasing the workload on the heart. Ramipril also reduces aldosterone secretion, which helps prevent sodium and fluid retention, offering additional cardiovascular protection. The 5 mg strength is typically prescribed as a maintenance dose for patients with hypertension, post-myocardial infarction, or heart failure who have been stabilized on lower doses. Beyond controlling blood pressure, Ramipril is known to provide cardio- and reno-protective effects, making it beneficial for patients with diabetes or chronic kidney disease to slow the progression of nephropathy.
Common side effects may include dizziness, headache, fatigue, and mild gastrointestinal disturbances. Hydrochlorothiazide may cause increased urination, dehydration, or electrolyte imbalances such as low potassium (hypokalemia) or sodium levels. Olmesartan can occasionally lead to low blood pressure (hypotension), particularly in volume-depleted patients, and rarely kidney function changes. In some patients, increased uric acid levels or photosensitivity reactions may occur. Monitoring of blood pressure, electrolytes, and kidney function is advised during long-term use.
Olmetyle 40H Tablet is indicated for the treatment of essential hypertension in adults, especially in patients who require combination therapy to achieve optimal blood pressure targets or are unresponsive to single-agent treatment.
Olmetyle 40H Tablet should only be used under the guidance of a qualified healthcare provider. It is contraindicated during pregnancy, particularly in the second and third trimesters, due to the risk of fetal toxicity and death. Caution should be exercised in patients with kidney or liver impairment, severe dehydration, or electrolyte disturbances. Avoid potassium supplements or potassium-sparing diuretics unless prescribed. Alcohol intake should be minimized, as it can enhance the blood pressure-lowering effect and increase dizziness. This medicine is not recommended during breastfeeding. Do not discontinue therapy abruptly without consulting your physician, and maintain regular follow-ups for blood pressure and laboratory monitoring.
Store Olmetyle 40H Tablet in a cool, dry place below 30°C. Keep away from moisture and direct sunlight. Retain in original packaging and keep out of the reach of children. Do not use beyond the expiry date mentioned on the strip.
Composition : Ramipril 10 mg tablet
Composition : Metoprolol Succinate 25mg + Ramipril 2.5mg Tablet
Composition : Metoprolol Succinate 50mg + Ramipril 5mg Tablet
Composition : Ramipril 1.25 mg tablet
Composition : Ramipril 2.5 mg tablet
Composition : Ramipril 5 mg + Hydrochlorothiazide 12.5 mg tablet
Composition : Ramipril 5 mg tablet
Composition : Ramipril 2.5 mg + amlodipine 5 mg tablet